In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

MediciNova, Inc.. Trade Record

NASDAQ:MNOV MediciNova, Inc. stock gains 15.61% Exit Sep 12, 2018 a Trade Record by priceseries

Trade Chart
Trade Chart MNOV Aug 23, 2018, priceSeries
About MediciNova, Inc.

MediciNova, Inc., a biopharmaceutical company, focuses on acquiring and developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company's product candidate includes MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for the treatment of neurological disorders, including primary and secondary progressive multiple sclerosis; amyotrophic lateral sclerosis; and substance dependence and addiction, including methamphetamine, opioid, and alcohol dependence. Its product pipeline also comprises MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic diseases, such as nonalcoholic steatohepatitis, idiopathic pulmonary fibrosis, and other fibrotic diseases; MN-221 (bedoradrine), a ß2-adrenergic receptor agonist for the treatment of acute exacerbation of asthma; and MN-029 (denibulin), a tubulin binding agent to treat solid tumor cancers. The company was founded in 2000 and is headquartered in La Jolla, California.

Trade Information
Trade Type
LONG
ReliabilityScore™
84.14
Entry Date
Aug 23, 2018
Entry Price
9.73
Sell Date
Sep 12, 2018
Sell Price
11.25
Net Gain
15.61%
Hold Time
13 Trading Days